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Abstract – This paper introduces javelin diagrams as an innovative way for depicting the results of
medical decision analyses. The methods were used to determine whether, and at which values, blood
lactate in Belgian White and Blue or maximum tidal volumes in Holstein calves should be measured
before deciding to treat or not a calf suffering from the bovine respiratory disease complex. The
different alternatives depended upon the probabilities of survival with and without treatment and
upon the costs associated with a possible death, the test and the treatment. The chosen alternative
was the one with the lowest expected costs. From data collected on the treated calves, the expected
costs of measuring lactate (198.01 €) and tidal volumes (27.38 €) before deciding to treat or not were
lower than the expected costs of directly treating sick Belgian Blue (215.39 €) and Holstein (51.55 €)
calves, respectively. The treatment should be applied to sick Belgian Blue calves with blood lactate
≤ 7.8 mmol/L and to Holstein calves with a maximum tidal volume ≥ 1.81 L. At such test values,
the treatment expected costs were lower than the expected costs associated with no treatment of
calves with other test values. Probabilistic sensitivity analyses showing benefits in treating animals
with a positive test (over not treating the animals with a negative test) were mostly invariant to
changes in any cost value but were sensitive to uncertainties in probabilities of survival with or
without treatment. The javelin diagrams provided a clear visual indication of such results. They
depicted how and by how much the benefits were affected by uncertainties in probabilities, they
proposed different information values associated with the chosen alternative, and identified
directions for further research. 
clinical decision analysis / javelin diagrams / bovine respiratory disease complex
1. INTRODUCTION
After they have reached their diagnosis,
veterinarians must decide whether or not to
treat a patient. Treatment may be indicated
when patients with advanced disease are at
risk of mortality in the face of continuous
disease progression. Conversely, treatment
may be withheld when its costs outweigh its
benefits. Veterinarians may perform a clin-
ical test to help them reach their decision.
They will decide to gather this additional
information if the expected cost of perform-
ing the test is lower than the expected cost
of directly treating the disease. At the very
least, this decision will depend upon the
sensitivity and specificity of the test in eval-
uating survival (the veterinarian will be
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more confident in a test accurate in identi-
fying surviving animals), and upon the
treatment (the veterinarian may be more
ready to perform the test if the treatment is
very expensive) or test costs (the veterinar-
ian will be less willing to do the test if it is
expensive). When the test is quantitative, it
is also necessary to define cut-off values to
distinguish between animals for which
doing the treatment is economically bene-
ficial from those for which not doing the
treatment is advantageous. 
Decision analysis methods provide a for-
mal framework to chose between different
alternatives: they quantify and combine in
an explicit way the information provided
and recommend to choose the alternative
which maximizes the expected value (or
minimizes the expected cost) among possi-
ble alternatives [10, 11]. Therefore, they are
particularly adequate for determining whether
or not a clinical test should be performed,
and at which test value the treatment should
be executed such that the chosen alternative
is the least costly. 
Uncertainty is inherent in such decision
and the chosen alternative may change
because sensitivities and specificities of the
test are usually observed on a small sample
and because knowledge of some variables,
such as costs and probabilities of survival,
is incomplete. A mathematical way to deal
with such uncertainties is to perform prob-
abilistic sensitivity analyses by providing
prior probability distributions to the varia-
bles and to compute post-hoc probability
distributions to the chosen alternative [8].
Recently, Felli and Hazen [6] proposed to
present the results of such sensitivity anal-
yses as javelin diagrams that display both
the robustness of the results (the degree to
which they fluctuate against deviations in
the input variables) and the information
value associated with the decision (the
expected gain in getting more information
on an uncertain input variable).
The objective of this paper was to intro-
duce javelin diagrams in veterinary medical
decision analyses. The analyses consisted
in determining whether or not the expected
costs of performing a clinical test before
deciding on treatment were lower than the
expected costs of directly treating a patient,
and at which test values treating it was less
expensive than not treating it. The best
alternative was chosen according to the
patient survival rates, costs of treatment and
test, and possible patient death. Data were
from studies on blood lactate and tidal vol-
umes in calves treated for the bovine respi-
ratory disease complex (BRDC). After choos-
ing an alternative, sensitivity analyses were
performed to determine the robustness of
the estimates obtained with the decision
analyses and the results are depicted in the
javelin diagrams. 
2. MATERIALS AND METHODS 
2.1. Clinical studies of the bovine 
respiratory disease complex
Respiratory disease may challenge the
oxygen transport chain in different ways,
e.g., through reduced oxygen transfer from
the lungs to the arterial blood or an elevated
oxygen consumption due to an increased
work of breathing. Therefore, studies were
undertaken by the Department of Physiol-
ogy of the Veterinary Faculty of Liège (Bel-
gium) in order to determine whether the
dosages of blood lactate (indirect assess-
ment of the oxygen level in tissues) and tidal
volume (lung function test) in calves suf-
fering from BRDC could be an index of dis-
ease severity. The BRDC was diagnosed
by veterinarians and indicated by laborious
breathing associated with either cough, nasal
discharge, fever, anorexia or adventitious
lung sounds on auscultation. 
In the first clinical study, 96 Belgian
White and Blue calves, all diagnosed with
BRDC, were followed from 28 days to
13 months of age [3]. At the start of the fol-
low-up period, the veterinarians sampled and
treated plasma lactate (PL) levels on each
calf. Treatment was standardized according
to the literature on the efficacy of known
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therapeutics and clinical signs such as rectal
temperature, respiratory rate, and partial
arterial oxygen pressure. During the fol-
low-up period, 74 calves recovered after a
treatment and 22 died. The treatment costs
averaged 25.94 ± 6.71 € and 52.5 ± 19.2 €
among recovering and incurable calves,
respectively. Venous blood lactate was ana-
lyzed immediately with a portable lactate
analyzer at a cost of 1.75 €. The PL values
increased from an average of 1.78 ±
0.10 mmol/L among calves recovering
with treatment up to 10.61 ± 1.21 mmol/L
among calves dying even after intensive
treatment. The calves were valued at around
800 ± 200 €. 
In the second study, veterinarians mea-
sured the maximum tidal volumes (TV) on
249 Holstein calves, after injection of a res-
piratory analeptic ([1], unpublished data).
Each calf respiratory flow was measured
with a heated pneumotachograph and the
TV were recorded with a digital acquisition
analysis program at a cost of 25 € (see [1]
for more technical details). The veterinari-
ans measured each calf, at the start of the
6-month survey, when calves presented no
clinical signs of BRDC. A total of 86 calves
developed the disease for which they were
all treated but seven of them died. The values
for TV averaged 1.41 ± 0.05 L and 1.19 ±
0.14 L in calves recovering or not from the
disease. The choice of medicine was left to
the veterinarians’ judgment and treatment
costs were obtained for each calf. They
averaged 40.24 ± 3.13 € among recovering
calves and 79.25 ± 20.04 € among dead
calves, not including the calves’ economic
values, estimated at 100 ± 25 €. 
2.2. Analyses
To illustrate the worth of the javelin dia-
grams, two questions were raised from the
information collected in both clinical stud-
ies. The first question was whether it would
have been economical to do the clinical test
before the treatment, i.e., whether the expected
costs of treating or not an animal based on
its test results (= ECTEST) were lower than
the expected costs of a treatment without a
test (= ECTRT). Since the values for PL and
TV are continuous, the individual ECTEST
were first computed at each observed value
of PL (from 1 to 15 mmol/L) and TV (from
0.66 to 3.08 L). Then, the overall ECTEST
was calculated as the weighted average of
all individual ECTEST, weighted by the fre-
quency of occurrence of each test value. 
The second issue was to identify PL and
TV cut-off values at which the expected
costs of treating a calf with a positive test
result (= ECTP) were lower than the expected
costs of not treating a calf with a negative
test result (= ECTN) or, equivalently, at
which ECDIFF = ECTN – ECTP was positive.
Under the assumption that veterinarians
would treat only sick calves with positive
results, i.e., calves with test values above
(or below) some threshold to be defined, the
four expected costs were computed as:
ECTRT = p(S+) × CMILD + [1 – p(S+)]
               × (CANL + CSEVERE) (1)
ECTEST = CTEST + p(S+∩T+) × CMILD
                 + p(S–∩T+) × (CSEVERE)
                 + p(S–) × CANL (2)
ECTP = p(T+) × CTEST 
             + p(S+∩T+) × CMILD 
               + p(S–∩T+) × (CSEVERE + CANL) 
(3)
ECTN = p(T–) × CTEST + p(S–∩T–) ×  CANL        
(4)
where the input variables are: CANL for the
economic loss due to the patient’s death,
CMILD for the treatment cost of a recovering
patient, CSEVERE for the treatment cost of
an incurable case, CTEST for the test cost,
p(S+) for the probability of survival,
p(S+∩T+) for the probability of survival
with a positive test, and p(S–∩T+) for the
probability of death with a positive test.
After having answered both matters, we
performed probabilistic sensitivity analy-
ses to determine how ECDIFF varied with
uncertainties in the input variables. Indeed,
probabilities of survival were biased in our
620 J.C. Detilleux
studies since no information on spontane-
ous cure was available. Uncertainties in the
probabilities and costs are represented by
beta and normal distributions, respectively
(with the exception of the test cost known
with certainty). The location and dispersion
parameters for both types of distributions
were set equal to their observed values
(Tab. I) and Monte Carlo simulation was
used to generate the distribution of ECDIFF.
The results are depicted as javelin diagrams
(Fig. 1). The expected costs were computed
with the matrix language SAS/IML [9],
either for each input distribution separately
(to obtain six javelin diagrams, one per
input variable, with the other variables
fixed at their observed value) or collec-
tively over the six distributions (to have one
overall diagram for all variables). In either
case, the left and right extremes of the jave-
lin represent the lowest and highest ECDIFF
values and relate to values in the lower and
upper tails of the input distributions. The
head of the javelin represents the positive
part of the distribution of ECDIFF. Only the
positive part needs to be shown because it
Table I. Mean (standard deviation) of the distribution of the input variables used in the decision
analyses.
Input variables Blood lactate Tidal volume
Probability of survival 0.77 (0.42) 0.97 (0.16)
Probability of a negative test result 0.13 (0.34) 0.17 (0.37)
Probability of a death with a negative test result 0.13 (0.34) 0.03 (0.18)
Probability of survival with a positive test result 0.77 (0.42) 0.17 (0.37)
Cost of treatment for a surviving patient (€) 25.94 (6.7) 40.24 (3.13)
Cost of treatment for a fatal case (€) 52.5 (18) 79.25 (20.04)
Animal economic value (€) 800 (65) 100 (25)
Figure 1. Javelin diagram representing the hypothetical variation in an output variable (plain line)
associated with a hypothetical distribution of a input variable (dashed line).
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represents the expected extra-gain associ-
ated with random changes in the input var-
iables while the left part would represent the
extra-loss. The likelihood and the average
of this expected extra-gain are represented
by the height and the average of the head of
the javelin, respectively. 
3. RESULTS 
In the PL study, the test was considered
as positive when PL was below some cut-
off value, because PL decreased with BRDC
severity. The observed expected costs were
ECTRT = 215.39 € and the overall ECTEST =
198.01 € which indicated that, in this exper-
iment, doing the test before deciding on treat-
ment was less costly than directly treating
the sick calves. The highest ECTP for which
ECTP < ECTN occurred for PL ≤ 7.8 mmol/L.
Indeed, at PL = 7.8 mmol/L, p(S–∩T–) =
0.13, p(S+) = p(S+∩T+) = 0.77 which gives
ECTP = 101.39 €, ECTN = 108.58 € and
ECDIFF = 108.58 – 101.39 = 7.19 €. Of
course, the choice of the cut-off value was
driven by the available data and was stained
by uncertainty. Consequently, the expected
benefit of treatment versus no-treatment
could possibly vary with changes in the
input variables. This variation is depicted
in the javelin diagram (Fig. 2). When all
Figure 2. Expected gains of treatment of Belgian White and Blue calves with a positive test (blood
lactate  7.8 mmol/L) over no-treatment of calves with a negative test: Javelin diagrams with
average expected gains (G) and likelihoods of positive gains (L) associated with random changes
in all and in the most influent input variables.
≤
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input variables are allowed to vary collec-
tively over all six distributions, the mini-
mum ECDIFF was –575 €, the maximum
was +806 €, and the average of the positive
ECDIFF was 135.56 €, which suggests ben-
efit of treatment of animals with PL ≤
7.8 mmol/L (over the expected costs of no
treatment of negative calves) may increase
even further than what was observed with
our data. When analyzing the changes in
ECDIFF by allowing each input variables to
vary separately over its own distribution,
one observes that ECDIFF was very sensi-
tive to changes in the probability of survival
with a positive test, in the probability of
death with a negative test and in the proba-
bility of a positive test (Fig. 2). On the con-
trary, it was mostly invariant to the eco-
nomic losses associated with the death of a
calf and to the costs of treatment (not shown
in Fig. 2). For example, the average of the
expected extra-gain associated to random
variation in p(T–) was 90.59 € but only 10 €
for variation in the animal economic value
(CANL).
In the TV study, the test was considered
positive when it was higher than some cut-
off value. The observed expected cost for
treating the respiratory symptoms with or
without knowledge of TV were ECTEST =
27.38 € and ECTRT = 51.55 €, respectively.
Here again, the alternative of doing the test
before treatment should be preferred over
treatment without knowledge of TV. The
highest ECTP for which ECTP < ECTN was
TV = 1.81 L. At this volume, ECTP = 7.95 €
and ECTN = 10.26 € which gives ECDIFF =
2.31 €. The variation in ECDIFF associated
with uncertainty in the input variables is
depicted in Figure 3. When input variables
are allowed to vary collectively, the average
positive extra-gain was 24.29 € with an
extreme minimum and maximum values of
–128 € and +112 €, respectively. As in the
PL study, ECDIFF was very sensitive to
changes in the probability of death with a
negative test, in the probability of survival
with a positive test, and in the probability
of a positive test. It was also mostly invar-
iant to changes in cost variables. 
4. DISCUSSION 
Because uncertainty is a critical fact
about medical reasoning [10, 11], veterinar-
ians must often make important decisions
based on incomplete knowledge of the
probability of survival of a sick animal. The
decision to either directly treat the patient
or to test it, and at which test values, may
be selected in a rational way by decision
analysis methods that estimate quantita-
tively the relative net value of the different
options [10, 11]. As an example, we iden-
tified that evaluating PL or TV before treat-
ing calves with BRDC was less expensive
than directly treating them. Within the lim-
its of our available data, the threshold in
Belgian White and Blue calves was at PL ≤
7.8 mmol/L and at TV ≥ 1.81 L in Holstein
calves. Coghe et al. [3] found that a PL cut-
off at 4 mmol/L is a reliable indicator for
mortality within 24 h. However, they obtained
the value using a Receiver Operating Char-
acteristic (ROC) curve [4, 7] and they
assumed the same clinical worth to false
positive and false negative results. However,
the costs of false positives (test positive
dead calves) were much higher than the
costs of false negatives (test negative sur-
viving calves) because they included calf
economic values. 
Of course, these results should be inter-
preted carefully since our study has several
limitations. Among others, we considered
only direct costs of treatment and animal
economic values. The analysis covered only
a short time-period after treatment and the
number of caves was rather small. We assigned
no penalty to treatment harms and, because
future expected production was unavaila-
ble, we used the economic values of the
calves at the time of the disease. Last, but
not least, we had no information on the
probability of survival among healthy and
untreated sick calves. It was therefore neces-
sary to perform sensitivity analysis to discover
for what variables additional information is
required [5, 8]. In our study, p(T–), p(S+∩T+),
and p(S–∩T–) were more influential than
economic variables in the determination of
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the best alternative. They are the critical uncer-
tainties on which research should focus to
have more accurate test threshold in deter-
mining animals for which treatment should
be the chosen alternative. 
Deterministic and probabilistic sensitiv-
ity analyses are the two main techniques to
analyze uncertainty [2, 8]. Probabilistic
methods are more popular because they
take account of both variability and uncer-
tainty in input variables and because they
provide a final distribution for the output.
Deterministic analyses give only point esti-
mates of the impact on the decision of
uncertainty in the input variables. Their
results may be displayed as tornado dia-
grams that reflect the extreme values in the
output associated with extreme values in
the input on a variable-by-variable basis.
Recently, Felli and Hazen [6] proposed an
extension of tornado diagrams, called the
javelin diagrams, to display the results of
probabilistic sensitivity analyses. For example,
in Holsteins (Fig. 3), when all input variables
Figure 3. Expected gains of treatment of Holstein calves with a positive test (maximum tidal
volume ≥ 1.8 L) over no-treatment of calves with a negative test: Javelin diagrams with average
expected gains (G) and likelihoods of positive gains associated (L) with random changes in all and
in the most influent input variables.
624 J.C. Detilleux
are allowed to vary collectively, the lowest
and highest values of the overall extra-gain
are represented by the left (–128 €) and right
(+112 €) extremes of the javelin. The head
of the javelin symbolizes the distribution of
the extra-gains. The height of the head rep-
resents the likelihood of gains (49.52%) and
the area under it represents the average
extra-gain (24.29 €). The javelin diagram
also shows the important changes in extra-
gain associated with uncertainty in the dif-
ferent input probabilities. Their individual
importance can be readily appreciated by
the size of the corresponding javelin heads,
the value of the average extra-gains and the
likelihood of observing positive extra-gains.
This may help in targeting further research
directions and in reducing effort in data col-
lection. 
Decision analysis methods may also be
used to determine how much veterinarians
should be willing to pay for a clinical test [5].
For example, at PL ≤ 7.8 mmol/L, ECTEST =
210 € and ECTRT = 215.39 €. The difference
215.39 € – 210 € = 5.39 € is the maximum
amount a veterinarian should be willing to
pay for the PL test. But, while the test was
completely specific in the sense that all ani-
mals with PL > 7.8 mmol/L died, it was
imperfect since 87% of the calves with PL ≤
7.8 mmol/L survived. If it had been totally
accurate in identifying both survived and
dead animals, the expected cost of perform-
ing the test would have decreased further
(ECTEST = 136.04 €).
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